Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.